prostate-report.org

Routine evaluation does not predict prostate cancer

A new study from the Mayo Clinic has emerged analyzing the link between prostate-specific antigen (PSA) levels and prostate size. The study concluded that routine annual evaluation of prostate growth cannot predict the development of prostate cancer.

However, the study suggests that a quickly rising PSA level should automatically prompted the need a biopsy to determine the possibility of prostate cancer. According to study leader, rising PSA levels are a great concern, but the amount of fluctuation between the numbers is only thing determining the need for a biopsy in cancer patients.